AvicatoninAlternative Names: MCI 536
Latest Information Update: 18 Dec 2003
At a glance
- Originator Mitsubishi Chemical
- Class Analgesics; Antihypercalcaemics; Osteoporosis therapies; Peptides
- Mechanism of Action Calcitonin stimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Inflammation; Pain
- Discontinued Postmenopausal osteoporosis